Italian Studies Validate HOPE’s Safety and Biomarker Utility in Liver Transplantation

Istanbul, Turkey – September 23, 2024 – Three pivotal studies from Italy on Hypothermic Oxygenated Perfusion (HOPE) in liver transplantation were presented at the 30th International Congress of The Transplantation Society

Portuguese Transplant Center Analysis of First 100 Cases of Hypothermic Oxygenated Perfusion (HOPE) in Liver Transplantation Demonstrates Increased Use of Marginal Grafts, Making More Livers Available for Transplantation

FOR IMMEDIATE RELEASE Analysis at ACS 2024 Highlights Benefits of Hypothermic Oxygenated Perfusion in Liver Transplantation San Francisco, California – October 21, 2024 – A compelling analysis involving 100 liver transplant cases

Bridge to Life Receives FDA 510(k) Clearance for Multi-Sourced Belzer UW® and MPS® Solutions with Expanded Labeling for MPS® Across All Abdominal Organs

Bridge to Life Receives FDA 510(k) Clearance for Multi-Sourced Belzer UW® and MPS® Solutions with Expanded Labeling for MPS® Across All Abdominal Organs Duluth, GA – October 7, 2025 – Bridge to

« Newer Stories